Mo Heidaran, PhD

Dr. Mo Heidaran is Head of Translational and Regulatory Strategy at GCTx (GC Therapeutics). He is a recognized expert in the development of cell and gene therapies with more than 9 years of experience at the FDA’s Center for Biologics Evaluation and Research (CBER), 15 years of biotech industrial experience in research, product and intellectual property development, and 9 years at the National Cancer Institute. He has more than 28 years of in-depth expertise in product, process development, process optimization, and scalable CGMP compliant biomanufacturing of cell and gene therapeutic products.